Literature DB >> 16903871

Sustained brain-derived neurotrophic factor up-regulation and sensorimotor gating abnormality induced by postnatal exposure to phencyclidine: comparison with adult treatment.

Makoto Takahashi1, Akiyoshi Kakita, Takashi Futamura, Yuichiro Watanabe, Makoto Mizuno, Kenji Sakimura, Eero Castren, Toshitaka Nabeshima, Toshiyuki Someya, Hiroyuki Nawa.   

Abstract

Brain-derived neurotrophic factor (BDNF) is involved in synaptic development and plasticity, and alterations in BDNF expression or signaling are implicated in drug addiction and psychiatric diseases, such as depression and schizophrenia. In this study, we administered phencyclidine to postnatal and adult rats with different time schedules, and determined the correlations between BDNF expression and the behavioral effects. Both single and repeated phencyclidine injections into adult rats induced BDNF up-regulation in the corticolimbic system and a decrease in prepulse inhibition, both of which were transient. In contrast, subchronic postnatal administration increased BDNF protein and mRNA levels in the hippocampus and entorhinal cortex, which were sustained until 8 weeks of age. In parallel, the postnatal rats treated with phencyclidine developed a persistent decrease in prepulse inhibition at the adult stage. The chronic BDNF increase appeared to contribute to the prepulse inhibition abnormality, as subchronic BDNF infusion into the hippocampus of normal rats mimicked the prepulse inhibition deficits. This study suggests that phencyclidine exposure during brain development induces sustained BDNF up-regulation in the limbic system with a biological link to sensorimotor gating deficits.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16903871     DOI: 10.1111/j.1471-4159.2006.04106.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  17 in total

1.  Construction and implantation of a microinfusion system for sustained delivery of neuroactive agents.

Authors:  Miles G Cunningham; Ryan P O'Connor; Sydney E Wong
Journal:  J Vis Exp       Date:  2008-03-17       Impact factor: 1.355

Review 2.  Animal models of schizophrenia.

Authors:  C A Jones; D J G Watson; K C F Fone
Journal:  Br J Pharmacol       Date:  2011-10       Impact factor: 8.739

Review 3.  Glutamatergic synaptic dysregulation in schizophrenia: therapeutic implications.

Authors:  Joseph T Coyle; Alo Basu; Michael Benneyworth; Darrick Balu; Glenn Konopaske
Journal:  Handb Exp Pharmacol       Date:  2012

4.  Brain activity mapping in Mecp2 mutant mice reveals functional deficits in forebrain circuits, including key nodes in the default mode network, that are reversed with ketamine treatment.

Authors:  Miriam Kron; C James Howell; Ian T Adams; Michael Ransbottom; Diana Christian; Michael Ogier; David M Katz
Journal:  J Neurosci       Date:  2012-10-03       Impact factor: 6.167

5.  N-Methyl d-Aspartate Receptor Expression Patterns in the Human Fetal Cerebral Cortex.

Authors:  Inseyah Bagasrawala; Fani Memi; Nevena V Radonjic; Nada Zecevic
Journal:  Cereb Cortex       Date:  2017-11-01       Impact factor: 5.357

Review 6.  Realistic expectations of prepulse inhibition in translational models for schizophrenia research.

Authors:  Neal R Swerdlow; Martin Weber; Ying Qu; Gregory A Light; David L Braff
Journal:  Psychopharmacology (Berl)       Date:  2008-06-21       Impact factor: 4.530

7.  Postnatal BDNF expression profiles in prefrontal cortex and hippocampus of a rat schizophrenia model induced by MK-801 administration.

Authors:  Chunmei Guo; Yang Yang; Yun'ai Su; Tianmei Si
Journal:  J Biomed Biotechnol       Date:  2010-06-27

8.  Prenatal phencyclidine treatment induces behavioral deficits through impairment of GABAergic interneurons in the prefrontal cortex.

Authors:  Kazuya Toriumi; Mika Oki; Eriko Muto; Junko Tanaka; Akihiro Mouri; Takayoshi Mamiya; Hyoung-Chun Kim; Toshitaka Nabeshima
Journal:  Psychopharmacology (Berl)       Date:  2016-04-20       Impact factor: 4.530

9.  Long-term effects of neonatal MK-801 treatment on prepulse inhibition in young adult rats.

Authors:  Takashi Uehara; Tomiki Sumiyoshi; Tomonori Seo; Hiroko Itoh; Tadasu Matsuoka; Michio Suzuki; Masayoshi Kurachi
Journal:  Psychopharmacology (Berl)       Date:  2009-04-16       Impact factor: 4.530

10.  Enhancement of social novelty discrimination by positive allosteric modulators at metabotropic glutamate 5 receptors: adolescent administration prevents adult-onset deficits induced by neonatal treatment with phencyclidine.

Authors:  Nicholas E Clifton; Nadège Morisot; Sylvie Girardon; Mark J Millan; Florence Loiseau
Journal:  Psychopharmacology (Berl)       Date:  2012-09-16       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.